肥満・糖尿病の外科治療　Web手術動画つき

出版社： メディカ出版
著者：
発行日： 2017-07-10
分野： 臨床医学：外科  >  消化器外科学
ISBN： 9784840461801
電子書籍版： 2017-07-10 （電子書籍版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

9,680 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

9,680 円(税込)

購入する

商品紹介

肥満外科治療は世界では年間50万件を超える。わが国でも2014年から腹腔鏡下スリーブ状胃切除術が保険適用となった。適応患者の見極め、術前の内科治療、手術、術後の長期フォローアップなどを各分野のスペシャリストが詳しく解説。脂肪の蓄積に応じた手術手技や難しい事態への対処法に加え、ポイントとなる手技をWeb動画で学べる。

目次

  • 肥満・糖尿病の外科治療　Web手術動画つき

    ―目次―

    【第1章 肥満症患者の病態と治療の基本】
    ◆1 性格特性を踏まえた肥満外科治療
    ◆2 肥満症の病態と治療体系
    ◆3 肥満症の診断と合併症
    ◆4 肥満症の治療：内科治療の位置づけ
    ◆5 肥満症の治療：外科治療の位置づけ
    ◆6 食事療法
    ◆7 運動療法：高度肥満患者への対応
    ◆8 行動療法
    ◆9 肥満症患者の心理行動特性のとらえ方と対処法
    ◆10 肥満症の病態を踏まえた治療戦略

    【第2章 肥満・糖尿病外科治療総論】
    ◆1 肥満症に対する外科治療の歩み
    ◆2 肥満外科手術の適応と種類
    ◆3 術式別の効果
    ◆4 糖尿病に対するMetabolic surgery の寛解機序
    ◆5 糖尿病以外の肥満関連健康障害に対する
    　　　Metabolic surgery の効果と今後の展望
    ◆6 Metabolic surgery の費用対効果
    ◆7 Metabolic surgery とインクレチン
    ◆8 Metabolic surgery と腸内細菌

    【第3章 肥満外科治療の実際】
    ◆1 手術手技
    （1）腹腔鏡下胃バイパス術
    （2）腹腔鏡下スリーブ状胃切除術
    （3）腹腔鏡下スリーブ状胃切除術＋十二指腸空腸バイパス術
    　　　（腹腔鏡下スリーブバイパス術）
    ◆2 肥満患者の麻酔管理
    ◆3 肥満外科手術の周術期管理
    ◆4 肥満外科手術の合併症とその対処法

    【第4章 肥満外科治療の準備とチーム医療】
    ◆1 チーム医療と各職種の役割
    ◆2 外科紹介のタイミングと症例検討会
    ◆3 術前減量プログラムと術後栄養管理の注意点
    ◆4 注意すべき肥満関連健康障害と周術期管理のポイント
    （1）睡眠時無呼吸症候群
    （2）心不全，冠動脈疾患
    （3）肥満関連腎臓病
    ◆5 糖尿病合併例の肥満外科治療における内科医師の役割
    ◆6 患者サポートグループの重要性
    ◆7 肥満外科治療後のリバウンド対策
    ◆8 治療困難例への対処の仕方

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 肥満症患者の病態と治療の基本

P.15 掲載の参考文献
1) 日本肥満症治療学会肥満外科治療ガイドライン策定委員会. 日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン (2013年版). 日本肥満症治療学会, 2013. http://plaza.umin.ne.jp/~jsto/gakujyutsu/updata/surgery_guideline_2013.pdf (2017年3月閲覧)
 
2) Sjostrom L, et.al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 357 (8), 2007, 741-52.
PubMed
3) Saito Y, et al. Effect of protein-sparing modified fasting on obese Japanese patients. Clin Biochem Nutr. 2, 1987, 91-100.
 
4) White MA, et al. Prognostic Significance of Depressive Symptoms on Weight Loss and Psychosocial Outcomes Following Gastric Bypass Surgery : A Prospective 24-Month Follow-Up Study. Obes Surg. 25 (10), 2015, 1909-16.
PubMed
5) 小山朝一ほか. ロールシャッハ・テストを用いた肥満症患者の性格特性分析 ハイラムダスタイルについて. 肥満研究. 15 (1), 2009, 39-44.
Medical*Online
6) 林果林ほか. 肥満症患者の心理的側面の特徴 : ロールシャッハ変数の比較分析から. 心身医学. 56, 2016, 920-30.
Medical*Online
7) 齋木厚人. わが国における肥満手術普及に向けて : 手術Before & After. 肥満外科治療後の患者を長期にfollow-upすることで見えてきたこと. 第34回日本肥満症治療学会学術集会. 抄録集. 2016年7月.
 
P.19 掲載の参考文献
1) 龍野一郎ほか. "臨床編 : 疾患と栄養". 新臨床栄養学 (第2版). 馬場忠雄ほか編. 医学書院, 2012, 360-6.
 
2) 龍野一郎. 肥満症の疫学と病態. 日本医事新報. 4698, 2014, 16-9.
Medical*Online
3) 龍野一郎. 肥満症の集学的治療. 日本医事新報. 4698, 2014, 20-8.
Medical*Online
4) 日本肥満学会肥満症治療ガイドライン作成委員会. 肥満症の診断基準2011. 肥満研究. 2011.
 
5) 日本肥満症治療学会編. 肥満症の総合的治療ガイド. 2013, 112p.
 
6) 日本肥満学会編. 肥満症診療ガイドライン2016. ライフサイエンス出版, 2016, 152p.
 
7) 厚生労働省. 平成27年度 国民健康・栄養調査結果の概要.
 
8) 小山朝一ほか. ロールシャッハテストを用いた肥満症患者の性格特性分析 : ハイラムダスタイルについて. 肥満研究. 15, 2009, 39-44.
 
P.24 掲載の参考文献
1) 日本肥満学会編. 肥満症診療ガイドライン2016. ライフサイエンス出版, 2016, 4-15.
 
2) 吉池信男. Body Mass Indexに基づく肥満の程度と糖尿病, 高血圧, 高脂血症のリスク因子との関連-多施設共同研究による疫学的検討. 肥満研究. 6, 2000, 4-17.
 
3) The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New Criteria for 'Obesity Disease' in Japan. Circ J. 66, 2002, 987-92.
 
4) Ryo M. Clinical significance of visceral adiposity assessed by computed tomography : A Japanese perspective. World J Radiol. 6, 2014, 409-16.
PubMed
5) Mottillo S. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 56, 2010, 1113-32.
PubMed
6) メタボリックシンドローム診断基準検討委員会. メタボリックシンドロームの定義と診断基準. 日本内科学会雑誌. 94, 2005, 794-809.
 
7) Knowler WC; for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346, 2002, 393-403.
PubMed
8) Lamon-Fava S. Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women. The Framingham Offspring Study. Arteriscler Thromb Vasc Biol. 16, 1996, 1509-15.
PubMed
9) 三浦克之 (研究代表者). 厚生労働省科学研究費補助金循環器疾患・糖尿病等生活習慣病対策総合研究事業「2010年国民健康栄養調査対象者の追跡開始 (NIPPON DATA 2010) とNIPPON DATA80/90の追跡継続に関する研究」平成24年度総括・分担研究報告書. 2013.
 
10) Hubert HB. Obesity as an independent risk factor for cardiovascular disease : a 26-year follow-up of participants in the Framingham Heart Study. Circ. 67, 1983, 968-77.
 
11) 日本消化器病学会編. NAFLD/NASH診療ガイドライン2014. 南江堂, 2014, 90-1.
 
12) Francois C. A Systematic Review of Glomerular Hyperfiltration Assessment and Definition in the Medical Literature. Clin J Am Soc Nephrol. 10, 2015, 382-9.
 
P.28 掲載の参考文献
1) 日本肥満学会編. 肥満症診療ガイドライン2016. ライフサイエンス出版, 2016, 152p.
 
2) 日本肥満学会肥満症治療ガイドライン作成委員会. 肥満症治療ガイドライン2006. 肥満研究. 12 (臨時増刊号), 2006.
 
P.32 掲載の参考文献
1) Angrisani L, et al. Bariatric Surgery Worldwide 2013. Obes Surg. 25, 2015, 1822-32.
PubMed
2) 北野正剛. 肥満・糖尿病に対する外科治療. 月刊糖尿病. 6, 2014, 5.
 
3) 太田正之ほか. 肥満症に対する外科手術の現状. 月刊糖尿病. 6, 2014, 6-12.
 
4) Dixon JB, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes : a randomized controlled trial. JAMA. 299, 2008, 316-23.
PubMed
5) Wentworth JM, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people : a randomised controlled trial. Lancet Diabetes Endocrinol. 2, 2014, 545-52.
PubMed
6) Mingrone G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes : 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 386, 2015, 964-73.
PubMed
7) Courcoulas AP, et al. Surgical vs medical treatments for type 2 diabetes mellitus : a randomized clinical trial. JAMA Surg. 149, 2014, 707-15.
PubMed
8) Ikramuddin S, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study) : 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol. 3, 2015, 413-22.
PubMed
9) Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes : 5-year outcomes. N Engl J Med. 376, 2017, 641-51.
PubMed
10) Sjostrom L, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 307, 2012, 56-65.
PubMed
11) Pontiroli AE, et al. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 253, 2011, 484-7.
PubMed
12) Haruta H, et al. Long-term outcomes of bariatric and metabolic surgery in Japan : Results of a multiinstitutional survey. Obes Surg. 7, 2017, 754-62.
 
P.37 掲載の参考文献
1) 日本肥満学会. 肥満症診療ガイドライン2016. ライフサイエンス出版, 2016.
 
2) Foster GD, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 348 (21), 2003, 2082-90.
PubMed
3) Sacks FM, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 360 (9), 2009, 859-73.
PubMed
4) Torgerson JS, et al. Effects on body weight of strict or liberal adherence to an initial period of VLCD treatment. A randomized, one-year clinical trial of obese subjects. Int J Obes Relat Metab Disord. 23 (2), 1999, 190-7.
PubMed
5) Shai I, et al. Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low - carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 359 (3), 2008, 229-41.
 
6) Das SK, et al. Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE : a 1-y randomized controlled trial. Am J Clin Nutr. 85 (4), 2007, 1023-30.
PubMed
7) Bravata DM, et al. Efficacy and safety of low-carbohydrate diets : a systematic review. JAMA. 289 (14), 2003, 1837-50.
PubMed
8) Nordmann AJ, et al. Effects of low-carbohydrate vs lowfat diets on weight loss and cardiovascular risk factors : a meta-analysis of randomized controlled trials. Arch Intern Med. 166 (3), 2006, 285-93
 
9) Noto H, et al Low-carbohydrate diets and all-cause mortality : a systematic review and meta-analysis of observational studies. PLoS One. 8 (1), 2013, e55030.
PubMed
10) 宮下洋ほか. 肥満インスリン非依存型糖尿病患者に対する減量食成分比と糖脂質代謝変動. 糖尿病. 41 (10), 1998, 885-90.
 
11) Ramel A, et al. Consumption of cod and weight loss in young overweight and obese adults on an energy reduced diet for 8-weeks. Nutr Metab Cardiovasc Dis. 19 (10), 2009, 690-6.
 
12) Damms-Machado A, et al. Micronutrient deficiency in obese subjects undergoing low calorie diet. Nutr J. 11, 2012, 34.
PubMed
13) Fujii H, et al. Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus : the Fukuoka Diabetes Registry. Nutr J. 12, 2013, 159.
PubMed
14) Malik VS, et al. Sugar-sweetened beverages and weight gain in children and adults : a systematic review and meta-analysis. Am J Clin Nutr. 98 (4), 2013, 1084-102.
PubMed
15) Saiki A, et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes. 29 (9), 2005, 1115-20.
 
P.40 掲載の参考文献
1) Shada AL, et al. Aerobic exercise is associated with improved weight loss after laparoscopic adjustable gastric banding. Obes Surg. 23, 2013, 608-12.
PubMed
2) Egberts K, et al. Does exercise improve weight loss after bariatric surgery? A systematic review. Obes Surg. 22, 2012, 335-41.
PubMed
3) Jacobi D, et al. Physical activity and weight loss following bariatric surgery. Obes Rev. 12, 2011, 366-77.
PubMed
4) Herring LY, et al. Changes in physical activity behaviour and physical function after bariatric surgery : a systematic review and meta-analysis. Obes Rev. 17, 2016, 250-61.
PubMed
5) Livhits M, at al. Exercise following bariatric surgery : systematic review. Obes Surg. 20, 2010, 657-65.
 
6) Bonomi AG, et al. Weight-loss induced changes in physical activity and activity energy expenditure in overweight and obese subjects before and after energy restriction. PLoS One. 8 (3), 2013, e59641.
PubMed
7) Baillot A, et al. Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals : a systematic review and meta-analysis. PLos ONE. 10 (4), 2015, e0119017.
PubMed
8) Coen PM, et al. A role for exercise after bariatric surgery? Diabetes Obes Metab. 18, 2016, 16-23.
PubMed
9) Pouwels S, et al. Aspects of exercise before or after bariatric surgery : a systematic review. Obes Facts. 8, 2015, 132-46.
 
10) Fonseca-Junior SJ, et al. Physical exercise and morbid obesity : a systematic review. Arq Bras Cir Dig. 26 (Suppl. 1), 2013, 67-73.
 
11) Rudolph A, et al. Post-operative behavioural management in bariatric surgery : a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 14, 2013, 292-302.
PubMed
12) Nicklas BJ, et al. Increases in high-density lipoprotein cholesterol with endurance exercise training are blunted in obese compared with lean men. Metabolism. 46, 1997, 556-61.
PubMed
13) 日本肥満学会編. 肥満症診療ガイドライン2016. ライフサイエンス出版, 2016, 152p.
 
14) King WC, et al. The importance of preoperative and postoperative physical activity counseling in bariatric surgery. Exerc Sport Sci Rev. 41, 2013, 26-35.
PubMed
P.43 掲載の参考文献
1) 吉松博信. 肥満症の行動療法. 別冊・医学のあゆみ : 糖尿病・代謝症候群. 2004, 827-34.
 
2) 吉松博信ほか. 肥満症の行動療法. 日本内科学会雑誌. 90, 2001, 154-65.
 
3) 正木孝幸ほか. 肥満の治療 : 行動療法・心理療法・チーム医療. 内科. 117, 2016, 79-82.
 
P.47 掲載の参考文献
1) Charles S, et al. The psychology of obesity. Abdom Imaging. 37, 2012, 733-7.
 
2) Kalarchian MA, et al. Psychiatric disorders among bariatric surgery candidates : relationship to obesity and functional health status. Am J Psychiatry. 164, 2007, 328-34.
PubMed
3) Mauri M, et al. Axis I and II disorders and quality of life in bariatric surgery candidates. J Clin Psychiatry. 69, 2008, 295-301.
PubMed
4) Rosenberger PH, et al. Psychiatric disorder comorbidity and association with eating disorders in bariatric surgery patients : a cross-sectional study using structured interview-based diagnosis. J Clin Psychiatry. 67, 2006, 1080-5.
PubMed
5) 堀川直史ほか. 肥満症患者の行動と心理の特徴および手術後の心理的アプローチ. 肥満研究. 21, 2015, 1-7.
Medical*Online
6) 林果林ほか. 高度肥満症患者に併存する精神疾患 : うつ症状を中心に. 日本心療内科学会誌. 20, 2016, 267-72.
Medical*Online
7) Luppino FS, et al. Overweight, Obesity, and Depression. A systematic Review and Meta-analysis of Longitudinal Studies. Arch Gen Psychiatry. 67, 2010, 220-9.
PubMed
8) 林果林ほか. 肥満症患者の心理的側面の特徴 : ロールシャッハ変数の比較分析から. 心身医学. 56, 2016, 920.
Medical*Online
9) Yu ZB, et al. Intelligence in relation to obesity : a systematic review and meta-analysis. Obes Res. 11, 2010, 656-70.
 
P.56 掲載の参考文献
1) Lazar M. The humoral side of insulin resistance. Nat Med. 12, 2006, 43-4.
PubMed
2) Kadowaki T, et al. SnapShot : Physiology of Insulin Signaling. Cell. 148, 2012, 834.
PubMed
3) Kubota N, et al. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nat Commun. 7, 2016, 12977.
PubMed
4) Kubota T, et al. Imbalanced Insulin Actions in Obesity and Type 2 Diabetes : Key Mouse Models of Insulin Signaling Pathway. Cell Metab. 25, 2017, 797-810.
PubMed
5) Sakurai Y, et al. Role of insulin receptor substrate in the progression of hepatocellular carcinoma. Scientific Reports. 2017, in press.
 
6) Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 17, 2013, 185-96.
PubMed
7) Yamauchi T, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 423, 2003, 762-9.
PubMed
8) Okada-Iwabu M, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature. 503, 2013, 493-9.
PubMed
9) Tanabe H, et al. Crystal structures of the human adiponectin receptors. Nature. 520, 2015, 312-6.
PubMed

第2章 肥満・糖尿病外科治療総論

P.61 掲載の参考文献
1) Balsiger BM, et al. Bariatric surgery. Surgery for weight control in patients with morbid obesity. Med Clin North Am. 84 (2), 2000, 477-89.
PubMed
2) Payne JH, et al. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 106, 1963, 273-89.
PubMed
3) Mason EE, et al. Gastric bypass in obesity. Surg Clin North Am. 47 (6), 1967, 1345-51.
PubMed
4) Scopinaro N, et al. A case of severe obesity treated jejunoileal bypass. 1-year clinical course. Minerva Chir. 31 (8), 1976, 341-59.
PubMed
5) Kasama K, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass : technique and preliminary results. Obes Surg. 19 (10), 2009, 1341-5.
 
6) Angrisani L, et al. Bariatric Surgery Worldwide 2013. Obes Surg. 25 (10), 2015, 1822-32.
PubMed
7) Angrisani L, et al. Bariatric Surgery and Endoluminal Procedures : IFSO Worldwide Survey 2014. Obes Surg. 2017. [Epub ahead of print]
 
8) 川村功ほか. 肥満症に対する積極的治療 : とくに外科的治療の導入について. 医学のあゆみ. 126 (1), 1983, 8-13.
 
9) 川村功. 日本における肥満症外科治療法のあゆみ : 手術手技を中心に. 日本臨床外科学会雑誌. 72 (3), 2011, 537-49.
 
10) Adams TD, G et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 357 (8), 2007, 753-61.
 
11) Standards of Medical Care in Diabetes-2017. Diabetes Care. 40 (Suppl 1), 2017, S1-135.
 
P.66 掲載の参考文献
1) 川村功ほか. Metabolic surgeryとしての肥満外科手術の歴史と現状. 外科. 107 (6), 2006, 305-11.
 
2) Ohta M, et al. Initial Japanese experience with the LAPBAND system. Asian J Endosc Surg. 6 (1), 2013, 39-43.
PubMed
3) Kasama K, et al. Has laparoscopic bariatric surgery been accepted in Japan? The experience of a single surgeon. Obes Surg. 18 (11), 2008, 1473-8.
PubMed
4) Kasama K, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass : technique and preliminary results. Obes Surg. 19 (10), 2009, 1341-5.
 
5) 日本肥満症治療学会肥満外科治療ガイドライン策定委員会. 日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン (2013年版). http://plaza.umin.ne.jp/~jsto/gakujyutsu/index.html (2017.3.6参照)
 
6) 日本肥満学会編. "外科療法". 肥満症診療ガイドライン2016. ライフサイエンス出版, 2016, 64-5.
 
7) 日本糖尿病学会. "肥満を伴う糖尿病 (メタボリックシンドロームを含む)". 糖尿病診療ガイドライン2016. 日本糖尿病学会編. 南江堂, 2016, 307-28.
 
8) Lee WJ, et al. Bariatric surgery : Asia-Pacific perspective. Obes Surg. 15 (6), 2005, 751-7.
 
9) Lakdawala M, et al. Report : Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type II diabetes mellitus in the Asian population. Obes Surg. 20 (7), 2010, 929-36.
PubMed
10) Kasama K, et al. IFSO-APC Consensus Statement 2011. Obes Surg. 22 (5), 2012, 677-84.
 
11) Zimmet P, et al. IDF's view of bariatric surgery in type 2 diabetes. Lancet. 378 (9786), 2011, 108-10.
PubMed
12) Rubino F, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes : a Joint Statement by International Diabetes Organizations. Diabetes Care. 39 (6), 2016, 861-77.
PubMed
13) Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes? 5-year outcomes. N Engl J Med. 376 (7), 2017, 641-51.
PubMed
14) Lee WJ, et al. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus : predicting the success by ABCD score. Surg Obes Relat Dis. 11 (5), 2015, 991-6.
PubMed
15) Lee WJ, et al. Metabolic surgery for diabetes treatment : sleeve gastrectomy or gastric bypass? World J Surg. 41 (1), 2017, 216-23.
 
P.73 掲載の参考文献
1) 日本内視鏡下肥満・糖尿病外科研究会 : 腹腔鏡下肥満外科手術と内視鏡的胃内バルーン留置術の第3回アンケート調査結果報告. 2013.
 
2) Buchwald H, et al. Bariatric surgery : a systematic review and meta-analysis. JAMA. 292, 2004, 1724-37.
PubMed
3) Brethauer SA, et al. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 5, 2009, 469-75.
PubMed
4) Ricci C, et al. Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia : a meta-analysis and meta-regression study with 5-year follow-up. Obes Surg. 25, 2015, 397-405.
PubMed
5) Osland E, et al. Changes in non-diabetic comorbid disease status following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures : a systematic review of randomized controlled trials. Obes Surg. 27, 2017, 1208-21.
PubMed
6) Ribaric G, et al. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy : a systematic review and meta-analysis. Obes Surg. 24, 2014, 437-55.
PubMed
7) Sjostrom L, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 311, 2014, 2297-304.
PubMed
8) Peterli R, et al. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass or Sleeve Study (SM-BOSS). Ann Surg. 265, 2017, 466-73.
PubMed
9) Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes. N Engl J Med. 376, 2017, 641-51.
PubMed
10) Haruta H, et al. Long-term outcomes of bariatric and metabolic surgery in Japan : results of a multi-institutional survey. Obes Surg. 27, 2017, 754-62.
PubMed
11) Seki Y, et al. Long-term outcome of laparoscopic sleeve gastrectomy in morbidly obese Japanese patients. Obes Surg. 26, 2016, 138-45.
PubMed
12) Uno K, et al. A comparison of the bariatric procedures that are performed in the treatment of super morbid obesity. Obes Surg. [Epub ahead of print]
 
13) Brethauer SA, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 11, 2015, 489-506.
PubMed
14) Lee WJ, et al. Predicting success of metabolic surgery : age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 9, 2013, 379-84.
PubMed
P.78 掲載の参考文献
1) Buchwald H. Metabolic surgery : a brief history and perspective. Surg Obes Relat Dis. 6 (2), 2010, 221-2.
PubMed
2) Kindel TL, et al. Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg. 13 (10), 2009, 1762-72.
PubMed
3) Laferrere B, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 93 (7), 2008, 2479-85.
PubMed
4) Rubino F, et al. The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes. Ann Surg. 244 (5), 2006, 741-9.
PubMed
5) Thaler JP, et al. Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery. Endocrinology. 150 (6), 2009, 2518-25.
PubMed
6) le Roux CW, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 243 (1), 2006, 108-14.
PubMed
7) Ryan K, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 509, 2014, 183-8.
PubMed
8) Miyachi T, et al. Biliopancreatic limb plays an important role in metabolic improvement after duodenaljejunal bypass in a rat model of diabetes. Surgery. 159 (5), 2016, 1360-71.
 
9) Herder C, et al. Adiponectin and bariatric surgery : associations with diabetes and cardiovascular disease in the Swedish Obese Subjects Study. Diabetes Care. 37 (5), 2014, 1401-9.
PubMed
10) Chen J, et al. Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery. Surg Endosc. 26 (5), 2012, 1476-80.
PubMed
11) Netto BD, et al. Roux-en-Y Gastric Bypass Decreases Pro-inflammatory and Thrombotic Biomarkers in Individuals with Extreme Obesity. Obes Surg. 25 (6), 2015, 1010-8.
PubMed
12) Tremaroli V, et al, Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab. 22 (2), 2015, 228-38.
PubMed
13) Ochner CN, et al. The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity. Physiology & behavior. 100 (5), 2010, 549-59.
PubMed
14) Mithieux G. A novel function of intestinal gluconeogenesis : central signaling in glucose and energy homeostasis. Nutrition. 25 (9), 2009, 881-4.
PubMed
15) Mithieux G. Influence of diabetes surgery on a gutbrain-liver axis regulating food intake and internal glucose production. Nutr Hosp. 28 (Suppl 2), 2013, 109-14.
 
P.84 掲載の参考文献
1) Seki Y, et al. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. J Gastroenterol. 51 (3), 2016, 281-9.
PubMed
2) Mummadi RR, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease : systematic review and meta-analysis. Clin Gastroenterol Hepatol. 6 (12), 2008, 1396-402.
PubMed
3) Lassailly G, et al. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. Gastroenterology. 149 (2), 2015, 379-88, quiz e315-76.
 
4) Greenburg DL, et al. Effects of surgical weight loss on measures of obstructive sleep apnea : a meta-analysis. Am J Med. 122 (6), 2009, 535-42.
PubMed
5) Buchwald H, et al. Bariatric surgery : a systematic review and meta-analysis. JAMA. 292 (14), 2004, 1724-37.
PubMed
6) Sarkhosh K, et al. The impact of bariatric surgery on obstructive sleep apnea : a systematic review. Obes Surg. 23 (3), 2013, 414-23.
PubMed
7) Springer BD, et al. Obesity and the role of bariatric surgery in the surgical management of osteoarthritis of the hip and knee : a review of the literature. Surg Obes Relat Dis. 13 (1), 2017, 111-8.
 
8) Musella M, et al. Effect of bariatric surgery on obesityrelated infertility. Surg Obes Relat Dis. 8 (4), 2012, 445-9.
PubMed
9) Jamal M, et al. Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates : a 9-year analysis. Surg Obes Relat Dis. 8 (4), 2012, 440-4.
 
10) Kubik JF, et al. The impact of bariatric surgery on psychological health. J Obes. 2013, 837989.
PubMed
11) Bhatti JA, et al. Self-harm Emergencies After Bariatric Surgery : A Population-Based Cohort Study. JAMA Surg. 151 (3), 2016, 226-32.
PubMed
12) Kovacs Z, et al. Risk of psychiatric disorders, self-harm behaviour and service use associated with bariatric surgery. Acta Psychiatr Scand. 135 (2), 2017, 149-58.
PubMed
13) Morgan DJ, et al. Incidence and Risk Factors for Deliberate Self-harm, Mental Illness, and Suicide Following Bariatric Surgery : A State-wide Populationbased Linked-data Cohort Study. Ann Surg. 265 (2), 2017, 244-52.
PubMed
P.89 掲載の参考文献
1) 柿原浩明ほか. 滋賀医大と四谷メディカルキューブ症例による検討 An Economic Evaluation of Bariatric Surgeries in Japan. 肥満研究. 20 (2), 2014, 94-101.
 
2) Hoerger TJ, et al. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 33 (9), 2010, 1933-9.
PubMed
3) Song HJ, et al. Bariatric surgery for the treatment of severely obese patients in South Korea--is it cost effective?. Obes Surg. 23 (12), 2013, 2058-67.
PubMed
4) Tang Qi, et al. Cost-Effectiveness of Bariatric Surgery for Type 2 Diabetes Mellitus : A Randomized Controlled Trial in China. Medicine (Baltimore). 95 (20), 2016, e3522.
PubMed
5) Angrisani L, et al. Bariatric Surgery Worldwide. Obes Surg. 25 (11), 2015, 2166-8.
PubMed
6) Choi YB. Current Status of Bariatric and Metabolic Surgery in Korea. Endocrinol Metab (Seoul). 31 (4), 2016, 525-32.
PubMed
7) Pories WJ. Bariatric Surgery : Risks and Rewards. J Clin Endocrinol Metab. 93 (11 Suppl 1), 2008, S89-96.
 
8) 日本肥満症治療学会肥満外科治療ガイドライン策定委員会. 日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン (2013年版). 日本肥満症治療学会, 2013. http://plaza.umin.ne.jp/~jsto/gakujyutsu/index.html (2017年4月閲覧)
 
P.94 掲載の参考文献
1) Knop FK. Resolution of type 2 diabetes following gastric bypass surgery : involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia. 52, 2009, 2270-6.
PubMed
2) Wang TT, et al. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg. 247, 2008, 968-75.
 
3) Ramzy AR, et al. Ileal transposition surgery produces ileal lengthdependent changes in food intake, body weight, gut hormones and glucose metabolism in rats. Int J Obes. 38, 2014, 379-87.
 
4) Salehi M, et al. Blockade of Glucagon-like Peptide 1 Receptor Corrects Postprandial Hypoglycemia After Gastric Bypass. Gastroenterology. 146, 2014, 669-80.
PubMed
5) Chambers AP, et al. Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in Rats. Gastroenterology. 141, 2011, 950-8.
PubMed
6) Ugi S, et al. Laparoscopic sleeve gastrectomy leads to rapid improvement of glucose tolerance and insulin secretion with enhanced glucagon-like peptide (GLP-1) secretion. Diabetol Int. 1, 2010, 99-103.
 
7) Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 87, 2007, 1409-39.
PubMed
8) Mokadem M, et al. Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Mol Metab. 3, 2013, 191-201.
PubMed
9) Wilson-Perez HE, et al. Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency. Diabetes. 62, 2013, 2380-5.
PubMed
10) Vette ML, et al. GLP-1 Plays a Limited Role in Improved Glycemia Shortly After Roux-en-Y Gastric Bypass : A Comparison With Intensive Lifestyle Modification. Diabetes. 64, 2015, 434-46.
 
11) Service GJ, et al. Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery. N Eng J Med. 353, 2002, 249-54.
 
12) Lindqvist A, et al. Gastric Bypass Improves b-Cell Function and Increases b-Cell Mass in a Porcine Model. Diabetes. 63, 2014, 1665-71.
 
13) Jorgensen NB, et al. Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes. Diabetes. 62, 2013, 3044-52.
 
14) Dutia R, et al. Limited recovery of b-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 63, 2014, 1214-23.
 
P.98 掲載の参考文献
1) Walters WA, et al. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett, 588, 2014, 4223-33.
PubMed
2) Kawano Y, et al. Colonic Pro-inflammatory Macrophages Cause Insulin Resistance in an Intestinal Ccl2/Ccr2-Dependent Manner. Cell Metab, 24, 2016, 295-310.
 
3) de la Cuesta-Zuluaga J, et al. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. Diabetes Care. 40, 2017, 54-62.
PubMed
4) Kimura I, et al. The gut microbiota suppresses insulinmediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 4, 2013, 1829.
PubMed
5) Kusumoto Y, et al. Bile acid binding resin prevents fat accumulation through intestinal microbiota in high-fat diet-induced obesity in mice. Metabolism, 71, 2017, 1-6.
PubMed
6) Zhang H, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A, 106, 2009, 2365-70.
PubMed
7) Furet JP, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss : links with metabolic and low-grade inflammation markers. Diabetes, 59, 2010, 3049-57.
PubMed
8) Damms-Machado A, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015, 806248.
PubMed
9) Kong LC, et al. Gut microbiota after gastric bypass in human obesity : increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 98, 2013, 16-24.
PubMed
10) Li JV, et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut. 60, 2011, 1214-23.
PubMed
11) Liou AP, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 5, 2013, 178ra141.
PubMed
12) Ryan KK, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature, 509, 2014, 183-8.
PubMed
13) Karlsson FH, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 498, 2013, 99-103.
PubMed
14) Tremaroli V, et al. Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab. 22, 2015, 228-38.
PubMed
15) Simonen M, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Rouxen-Y gastric bypass. Obes Surg. 22, 2012, 1473-80.
 
16) Nakatani H, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 58, 2009, 1400-7.
PubMed

第3章 肥満外科治療の実際

P.108 掲載の参考文献
1) Mason EE, et al. Gastric bypass in obesity. Surg Clin North Am. 47 (6), 1967, 1345-51.
PubMed
2) Wittgrove AC, et al. Laparoscopic Gastric Bypass, Roux-en-Y : Preliminary Report of Five Cases. Obes Surg. 4 (4), 1994, 353-7.
PubMed
3) Buchwald H, et al. Metabolic/Bariatric Surgery Worldwide 2011. Obes Surg. 23, 2013, 427-36.
PubMed
4) Lee WJ, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus : a randomized controlled trial. Arch Surg. 146, 2011, 143-8.
PubMed
5) 稲嶺進ほか. 病的肥満に対する腹腔鏡下Roux-Y 胃バイパス術の手技. 手術. 61, 2007, 1647-54.
 
6) 稲嶺進ほか. 病的肥満と2型糖尿病の治療としての腹腔鏡下Roux-Y胃バイパス術の手技. 手術. 68, 2014, 1165-71.
 
7) Higa KD, et al. Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity Technique and Preliminary Results of Our First 400 Patients. Arch Surg. 135, 2000, 1029-33.
PubMed
8) 笠間和典ほか. "外科治療の適応". 肥満症の総合的治療ガイド. 齋藤康ほか監修. 日本肥満症治療学会. 2013, 66-7.
 
P.115 掲載の参考文献
1) Sasaki A, et al. Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes. J Gastroenterol. 49 (1), 2014, 57-63.
PubMed
2) Regan JP, et al. Early experience with two stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 13 (6), 2003, 861-4.
PubMed
3) Spaniolas K, et al. The changing bariatric surgery landscape in the USA. Obes Surg. 25 (8), 2015, 1544-6.
PubMed
4) Melissas J, et al. Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program. Obe Surg. 27 (4), 2017, 847-55.
 
5) Sasaki A, et al. Results of laparoscopic sleeve gastrectomy as a single stage bariatric procedure in Japanese patients. Asian J Endosc Surg. 3 (4), 2010, 180-4.
 
6) 佐々木章ほか. 腹腔鏡下スリーブ状胃切除術の手術手技と効果. 月刊糖尿病. 6 (4), 2014, 44-9.
 
7) 佐々木章ほか. 高度肥満症に対する腹腔鏡下スリーブ状胃切除術. 消化器外科. 39 (7), 2016, 975-87.
 
P.123 掲載の参考文献
1) Kasama K, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass : technique and preliminary results. Obes Surg. 19 (10), 2009, 1341-5.
 
2) Lee WJ, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus : a randomized controlled trial. Arch Surg. 146 (2), 2011, 143-8.
PubMed
3) Lee WJ, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients : efficacy and change of insulin secretion. Surgery. 147 (5), 2010, 664-9.
PubMed
4) Rosenthal R, et al. Effect of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Relat Dis. 5 (4), 2009, 429-34.
PubMed
P.130 掲載の参考文献
1) Wolk R, et al. Obesity, sleep apnea, and hypertension. Hypertension. 42 (6), 2003, 1067-74.
PubMed
2) Jones RL, et al. The effects of body mass index on lung volumes. Chest. 130 (3), 2006, 827-33.
PubMed
3) Benumof, J. et al. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1mg/kg intravenous succinylcholine. Anesthesiology. 87, 1997, 979-82.
 
4) ASA Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway an updated report by the American Society of Anesthesiologists Task Force on Management off the Difficult Airway. Anesthesiology. 98, 2003, 1269-77.
 
5) Japanese society of Anesthesiologists. JSA airway management guideline 2014 : to improve the safety of induction of anesthesia. J Anesth. 28, 2014, 482-93.
PubMed
6) Brodsky JB, et al. Morbid obesity and tracheal intubation. Anesth Analg. 94, 2002, 732-6.
PubMed
7) Dixon BJ, et al. Preoxygenation is more effective in the 25° head-up position than in the supine position in severely obese patients. Anesthesiology. 102, 2005, 1110-5.
 
8) Tagaito Y, et al. Sitting posture decreases collapsibility of the passive pharynx in anesthetized paralyzed patients with obstructive sleep apnea. Anesthesiology. 113, 2010, 812-8.
PubMed
9) Garcia RM, et al. The obesity supine sudden death syndrome in the perioperative Patient. Crit Care & Shock. 4, 2014, 82-4.
 
10) Nimmagadda U, et al. Preoxygenation with tidal volume and Deep breathing techniques : the impact of duration of breathing and fresh gas flow. Anes Analg. 92, 2001, 1337-41.
 
11) Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 342, 2000, 1301-8.
PubMed
12) Lemmens HJ, et al. Estimating blood volume in obese and morbidly obese patients. Obes Surg. 16, 2006, 773-6.
PubMed
13) Servin F, et al. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology. 78, 1993, 657-65.
PubMed
14) Pieracci FM, et al. Critical care of the bariatric patient. Crit Care Med. 34, 2006, 1796-804.
PubMed
15) Gould MK, et al. Prevention of VTE in nonorthopedic surgical patients : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141 (2 Suppl), 2012, e227S-77S.
 
P.137 掲載の参考文献
1) Gronkjaer M, et al. Preoperative smoking status and postoperative complications : a systematic review and meta-analysis. Ann Surg. 259, 2014, 52-71.
PubMed
2) Haskins IN, et al. The effect of smoking on bariatric surgical outcomes. Surg Endosc. 28, 2014, 3074-80.
PubMed
3) Moser F, et al. Relationship Between Tobacco Use and Weight Loss After Bariatric Surgery. Obes Surg. 26, 2016, 1777-81.
PubMed
4) 白石としえ. 術後管理 : 肥満患者の術後管理 : 生理的変化と合併疾患, アウトカム, 術後管理のポイントとその実際 : 肥満における術後管理のポイント. Intensivist. 4, 2012, 365-7, 371-4.
 
5) Benumof JL, et al. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology. 87, 1997, 979-82.
 
6) 中村真ほか. 静脈血栓塞栓症 : 静脈血栓塞栓症予防ガイドライン. 医療機器学. 78, 2008, 886-93.
Medical*Online
7) Ogden CL, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 295, 2006, 1549-55.
PubMed
8) Bartlett MA, et al. Prevention of venous thromboembolism in patients undergoing bariatric surgery. Vasc Health Risk Manag. 11, 2015, 461-77.
PubMed
9) Freire RH, et al. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 28, 2012, 53-8.
PubMed
P.142 掲載の参考文献
1) Abou Rached A, et al. Gastric leaks post sleeve gastrectomy : Review of its prevention and management. World J Gastroenterol. 20 (38), 2014, 13904-10.
 
2) Rosenthal RJ, et al. International Sleeve Gastrectomy Expert Panel Consensus Statement : best practice guidelines based on experience of ＞12,000 cases. Surg Obes Relat Dis. 8 (1), 2012, 8-19.
 
3) Oshiro T, et al. Successful management of refractory staple line leakage at the esophagogastric junction after a sleeve gastrectomy using the HANAROSTENT. Obes Surg. 20 (4), 2010, 530-4.
PubMed
4) Oshiro T, et al. Percutaneous transesophageal gastrotubing for management of gastric leakage after sleeve gastrectomy. Obes Surg. 24 (9), 2014, 1576-80.
PubMed
5) Mahadev S, et al. Endoscopic septotomy : an effective approach for internal drainage of sleeve gastrectomyassociated collections. Endoscopy. 49 (5), 2017, 504-8.
PubMed
6) Manos T, et al. How to treat stenosis after sleeve gastrectomy? Surg Obes Relat Dis. 13 (2), 2017, 150-4.
PubMed
7) Eisendrath P, et al. Major complications of bariatric surgery : endoscopy as first-line treatment. Nat Rev Gastroenterol Hepatol. 12 (12), 2015, 701-10.
PubMed
8) Parikh A, et al. Management options for symptomatic stenosis after laparoscopic vertical sleeve gastrectomy in the morbidly obese. Surg Endosc. 26 (3), 2012, 738-46.
PubMed
9) Chang PC, et al. Surgical standardization to prevent gastric stenosis after laparoscopic sleeve gastrectomy : a case series. Surg Obes Relat Dis. 13 (3), 2017, 385-90.
PubMed
10) Stenard F, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 21 (36), 2015, 10348-57.
PubMed

第4章 肥満外科治療の準備とチーム医療

P.149 掲載の参考文献
1) 日本肥満症治療学会肥満外科治療ガイドライン策定委員会. 日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン (2013年版). 2013.
 
2) McGavock JM, et al. American College of Physicians and the American Physiological Society. Adiposity of the heart, revisited. Ann Intern Med. 144 (7), 2006, 517-24.
PubMed
3) Lewis MC, et al. Change in liver size and fat content after treatment with Optifast very low calorie diet. Obesity Surgery. 16, 2006, 697-701.
PubMed
4) 齋木厚人ほか. フォーミュラ食の1食置き換えによる肥満外科治療後の栄養学的フォローアップ (術後12か月間の検討). 日本臨床栄養学会雑誌. 36 (2), 2014, 112-
 
5) Kalarchian MA, et al. Psychiatric disorders among bariatric surgery candidates : relationship to obesity and functional health status. Am J Psychiatry. 164 (2), 2007, 328-34.
PubMed
6) 林果林ほか. 高度肥満症患者に併存する精神疾患 : うつ症状を中心に. 日本心療内科学会誌. 20 (4), 2016, 267-72.
Medical*Online
7) 小山朝一ほか. ロールシャッハ・テストを用いた肥満症患者の性格特性分析 ハイラムダスタイルについて. 肥満研究. 15, 2009, 39-44.
Medical*Online
8) de Zwaan M, et al. Anxiety and depression in bariatric surgery patients : a prospective, follow-up study using structured clinical interviews. J Affect Disord. 133 (1-2), 2011, 61-8.
 
9) Mechanick JI, et al. American Association of Clinical Endocrinologists; Obesity Society ; American Society for Metabolic & Bariatric Surgery. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & amp; Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 17 Suppl 1, 2009, S1-70.
 
P.154 掲載の参考文献
1) 日本肥満症治療学会肥満外科治療ガイドライン策定委員会. 日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン (2013年版). 2013.
 
2) Schauer PR, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes. N Engl J Med. 376 (7), 2017, 641-51.
PubMed
3) American Diabetes Association. Approaches to glycemic treatment. Standards of Medical Care in Diabetes-2016. Diabetes Care. 39 (Supple. 1), 2016, S52-9.
 
4) Delahanty LM, et al. Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. Diabetes Care. 37 (10), 2014, 2738-45.
 
5) Romeo S, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 35 (12), 2012, 2613-7.
PubMed
6) Pontiroli AE, et al. Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 253 (3), 2011, 484-7.
PubMed
P.159 掲載の参考文献
1) Collins J, et al. Preoperative weight loss in high-risk superobese bariatric patients : a computed tomographybased analysis. Surg Obes Relat Dis. 7 (4), 2011, 480-5.
PubMed
2) Moize V, et al. Nutritional Intake and Prevalence of Nutritional Deficiencies Prior to Surgery in Spanish Morbidly Obese Population. Obes Surg. 21 (9), 2013, 1382-8.
 
3) Ernst B, et al. Evidence for the Necessity to Systematically Assess Micronutrient Status Prior to Bariatric Surgery. Obes Surg. 19 (1), 2009, 66-73.
 
4) Nicoletti CF, et al. New look at Nutritional care for obese patient candidates for bariatric surgery. Surg Obes Relat Dis. 9 (4), 2013, 520-5.
 
5) Jastrzebska-Mierzyeska M, et al. Assessment of dietary habits, nutritional tatus and blood biochemical parameters in patients prepared for bariatric surgery : a reliminary study. Wideochir Inne Tech Maloinwazyjne. 7 (3), 2012, 156-65.
 
6) Lo Menzo E, et al. Nutritional Implications of Obesity : Before and After Bariatric Surgery. Bariatr Surg Pract Patient Care. 9 (1), 2014, 9-17.
PubMed
7) Gletsu-Miller N, et al. Mineral malnutrition following bariatric surgery. Adv Nutr. 4 (5), 2013, 506-17.
PubMed
8) 吉川絵梨ほか. 高度肥満症に対する外科治療 (腹腔鏡下ルーワイ胃バイパス術) 術後の栄養指標, 食事量の変化. 日本臨床栄養学会雑誌. 34 (1), 2012, 2-7.
 
9) Mathes CM, et al. Food selection and taste change in humans after Roux-en-Y gastric bypass surgery : A direct- measures approach. Physiol Behav. 107 (4), 2012, 476-83.
PubMed
10) 吉川絵梨ほか. 減量手術後の食事満足度と食品許容度の評価. 日本病態栄養学会雑誌. 19 (4), 2016, 415-22.
 
11) Fanituch J, et al. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 14 (2), 2004, 175-81.
 
12) Dalcanale L, et al. Long-Term Nutritional Outcome After Gastric Bypass. Obes Surg. 20 (2), 2010, 181-7.
PubMed
13) Aasheim ET, et al. Vitamin status after bariatric surgery : a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 90 (1), 2009, 15-22.
PubMed
14) Suter M, et al. A New Questionnaire for Quick Assessment of Food tolerance after Bariatric Surgery. Obes Surg. 17 (1), 2007, 2-8.
 
P.165 掲載の参考文献
1) Chobanian AV, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure ; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure : the JNC 7 report. JAMA. 289, 2003, 2560-72.
 
2) Giles TL, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. (3) : CD001106, 2006.
 
3) Weinstock TG, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 35, 2012, 617-25.
 
4) Punjabi NM, et al. Sleep-disordered breathing and mortality : a prospective cohort study. PLoS Med. 6 : e1000132, 2009.
PubMed
5) Peppard PE, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 177, 2013, 1006-14.
PubMed
6) Yamagishi K, et al. Cross-cultural comparison of the sleep-disordered breathing prevalence among Americans and Japanese. Eur Respir J. 36, 2010, 379-84.
PubMed
7) ASMBS Clinical Issues Committee, et al. Perioperative management of obstructive sleep apnea. Surg Obes Relat Dis. 8, 2012, e27-32.
PubMed
8) Mokhlesi B, et al. Obesity hypoventilation syndrome : prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 11, 2007, 117-24.
PubMed
9) Chau EHL, et al. Obesity hypoventilation syndrome a review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology. 117, 2012, 118-205.
 
10) Hallowell PT, et al. Potentially life-threatening sleep apnea is unrecognized without aggressive evaluation. Am J Surg. 193, 2007, 364-7.
PubMed
11) Sheppard JW Jr. Hypertension, cardiac arrhythmias, myocardial infarction and stroke in relation to obstructive sleep apnea. Clin Chest Med. 13, 1992, 437-58.
 
12) DeMaria EJ, et al. Perioperative management of special populations : obesity. Surg Clin North Am. 85, 2005, 1283-9.
PubMed
13) Lockhart EM, et al. Obstructive sleep apnea screening and postoperative mortality in a large surgical cohort. Sleep Med. 14 (5), 2013, 407-15.
 
14) 福原俊一ほか. 日本語版the Epworth Sleepiness Scale (JESS). 日本呼吸器学会雑誌. 44 (11), 2006, 896-8.
Medical*Online
15) https://www.sleepmedicine.com/files/files/StopBang_Questionnaire.pdf (2017年4月閲覧)
 
16) Berry RB, et al. Rules for scoring respiratory events in sleep : update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. J Clin Sleep Med. 8 (5), 2012, 597-619.
PubMed
17) Phillips BA, et al. "Management of obstructive sleep apnea-hypopnea syndrome". Principles and Practice of Sleep Medicine. 5th ed. Kryger MH, et al. eds. Elsevier. 2011, 1278-93.
 
18) Foster GD, et al. ; Sleep AHEAD Research Group of Look AHEAD Research Group. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes : the Sleep AHEAD study. Arch Intern Med. 169, 2009, 1619-26.
 
19) Peppard PE, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 284, 2000, 3015-21.
PubMed
20) Gottlieb DJ, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 370, 2014, 2276-85.
PubMed
21) Aurora RN, et al. American Academy of Sleep Medicine. Practice parameters for the surgical modifications of the upper airway for obstructive sleep apnea in adults. Sleep. 33, 2010, 1408-13.
PubMed
22) ASMBS Clinical Issues Committee, et al. Perioperative management of obstructive sleep apnea. Surg Obes Relat Dis. 8, 2012, e27-32.
PubMed
23) Ramirez A, et al. Continuous positive airway pressure in immediate postoperative period after laparoscopic Rouxen-Y gastric bypass : is it safe? Surg Obes Relat Dis. 5, 2009, 544-6.
 
24) Sutherland K, et al. Oral appliance treatment for obstructive sleep apnea : an update. J Clin Sleep Med. 10, 2014, 215-27.
PubMed
25) Dixon JB, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea : a randomized controlled trial. JAMA. 308, 2012, 1142-9.
PubMed
P.168 掲載の参考文献
1) Devereaux PJ, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial) : a randomised controlled trial. Lancet. 371, 2008, 1839-47.
 
2) 日本循環器病学会. 慢性心不全治療ガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf (2017年3月閲覧)
 
3) Kenchaiah S, et al. Obesity and the risk of heart failure. N Engl J Med. 347 (5), 2002, 305-13.
PubMed
4) Alpert MA, et al. Obesity and heart failure : epidemiology, pathophysiology, clinical manifestations, and management. Transl Res. 164 (4), 2014, 345-56.
PubMed
5) Rader DJ, et al. Effect of insulin resistance, dyslipidemia, and intraabdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med. 120 (3 Suppl 1), 2007, S12-8
 
6) Lee YH, et al. Abdominal obesity and cardiovascular disease risk : the emerging role of the adipocyte. J Cardiopulm Rehabil Prev. 27 (1), 2007, 2-10.
PubMed
7) Eckel RH, et al. The metabolic syndrome. Lancet. 365 (9468), 2005, 1415-28.
PubMed
8) 日本循環器病学会. 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2014年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2014_kyo_h.pdf (2017年3月閲覧)
 
9) Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery, et al. Guidelines for pre-operative cardiac risk assessment andperioperative cardiac management in non-cardiac surgery. Eur Heart J. 30, 2009, 2769-812.
 
10) Lee TH, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 100 (10), 1999, 1043-9.
PubMed
P.172 掲載の参考文献
1) Hashimoto Y, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol, 10, 2015, 578-83.
PubMed
2) Kambham N, et al. Obesity-related glomerulopathy : an emerging epidemic. Kidney Int. 59, 2001, 1498-509.
PubMed
3) Tsujimoto T, et al. The dose-response relationship between body mass index and the risk of incident stage > 3 chronic kidney disease in a general japanese population : the Ibaraki prefectural health study (IPHS). J Epidemiol. 24, 2014, 444-51.
 
4) Hosoya K, et al. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans. Kidney Int. 87, 2015, 749-60.
PubMed
5) Kato S, et al. Pathological influence of obesity on renal structural changes in chronic kidney disease. Clin Exp Nephrol. 13, 2009, 332-40.
PubMed
6) Praga M, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant. 16, 2001, 1790-8.
PubMed
7) Tsuboi N, et al. Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathy. Clin Exp Nephrol. 17, 2013, 379-85.
PubMed
8) Iseki K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 65, 2004, 1870-6.
 
9) Mallamaci F, et al. ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol. 22, 2011, 1122-8.
PubMed
10) Suzuki H, et al. Eplerenone, an aldosterone blocker, is more effective in reducing blood pressure in patients with, than without, metabolic syndrome. Ther Adv Cardiovasc Dis. 6, 2012, 141-7.
PubMed
11) Tokuyama H, et al. Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury. Int J Obes (Lond). 36, 2012, 1062-71.
PubMed
12) Morales E, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 41, 2003, 319-27.
PubMed
13) Navaneethan SD, et al. Weight loss interventions in chronic kidney disease : a systematic review and metaanalysis. Clin J Am Soc Nephrol. 4, 2009, 1565-74.
PubMed
14) Navarro-Diaz M, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients : long-term follow-up. J Am Soc Nephrol. 17, 2006, S213-7.
PubMed
15) MacLaughlin HL, et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD : a randomized controlled pilot study. Am J Kidney Dis. 64, 2014, 660-3.
PubMed
16) Turgeon NA, et al. The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol. 23, 2012, 885-94.
PubMed
P.176 掲載の参考文献
1) American Diabetes Association. Obesity management for the treatment of type 2 diabetes. Sec.7. In Standards of Medical Care in Diabetes-2017. Diabetes Care. 40 (Suppl. 1), 2017, 557-63.
 
2) 日本肥満症治療学会肥満外科治療ガイドライン策定委員会. 日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン (2013年版). 日本肥満症治療学会, 2013. http://plaza.umin.ne.jp/~jsto/gakujyutsu/updata/surgery_guideline_2013.pdf (2017年5月閲覧)
 
3) 小山朝一ほか. ロールシャッハ・テストを用いた肥満症患者の性格特性分析. 肥満研究. 15 (1), 2009, 39-44.
Medical*Online
4) Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes. N Engl J Med. 376, 2017, 641-51.
PubMed
5) Conason A, et al. Substance use following bariatric weight loss surgery. JAMA Surg. 148, 2013, 145-50.
PubMed
6) Bhatti JA, et al. Self-harm emergencies after bariatric surgery. A population-based cohort study. JAMA Surg. 151, 2016, 226-32.
PubMed
7) Andalib A, et al. Diabetic ketoacidosis following bariatric surgery in patients with type 2 diabetes. Diabetes Care. 39, 2016, e121-2.
PubMed
8) 天本美里ほか. 治療抵抗性の高度肥満2型糖尿病に対し, 腹腔鏡下スリーブ状胃切除術後, 糖尿病薬物治療を中止しえた2例. 第17回日本内分泌学会関東甲信越地方会抄録集O12-3. 2016.
 
9) 関根哲生ほか. 高用量インスリン投与中の高度肥満2型糖尿病に対する腹腔鏡下スリーブ状胃切除術の治療効果. 第37回日本肥満学会抄録集O-026. 2016.
 
P.180 掲載の参考文献
1) 日本肥満症治療学会肥満外科治療ガイドライン策定委員会. "日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン (2013年版)". 日本肥満症治療学会. 2013.
 
2) 高松里. セルフヘルプ・グループとサポート・グループ実施ガイド : 始め方・続け方・終わり方. 金剛出版, 2004, 21-2.
 
3) Hildebrandt SE. Effects of participation in bariatric support group after Roux-en-Y gastric bypass. Obesity Surgery. 8 (5), 1998, 535-42.
PubMed
4) Nakazato T, et al. Patient/Family Support Groups in Japan : A Model to Ensure the Success of Bariatric Surgery. Bariatric Times. March 2009.
 
5) 黒木保博ほか. グループワークの専門技術 : 対人援助のための77の方法. 中央法規出版, 2001, 276p.
 
6) 保田井進ほか. 福祉グループワークの理論と実際. ミネルヴァ書房, 1999, 288p.
 
P.184 掲載の参考文献
1) Karmali S, et al. Weight recidivism post-bariatric surgery : a systematic review. Obes Surg. 23, 2013, 1922-33.
PubMed
2) Sjostrom L, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 357, 2007, 741-52.
PubMed
3) Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med. 370, 2014, 2002-13.
PubMed
4) Mingrone G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes : 5 year follow-up of an open-label, singlecentre, randomised controlled trial. Lancet. 386, 2015, 964-73.
PubMed
5) 佐藤哲子. "実践編 メタボチームの活動スタート". チームで撲滅! メタボリックシンドローム. 佐藤哲子編. 診断と治療社, 2009, 117-58.
 
6) Satoh-Asahara N, et al. Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients : a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study : JOMS). Atherosclerosis. 242, 2015, 461-8.
PubMed
7) Skilton MR, et al. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 62, 2007, 1251-7.
PubMed
8) Stanford FC, et al. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss : A multi-center study. Surg Obes Relat Dis. 13, 2017, 491-500.
PubMed
9) Maleckas A, et al. Weight regain after gastric bypass : etiology and treatment options. Gland Surg. 5, 2016, 617-24.
PubMed
10) Roslin M, et al. Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia. Surg Endosc. 25, 2011, 1926-32.
PubMed
P.189 掲載の参考文献
1) 日本肥満症治療学会メンタルヘルス部会編. "認知行動的特徴による肥満症患者4分類とそれに基づく対応". 肥満症治療に必須な心理的背景の把握と対応. 日本肥満症治療学会, 2016, 58-60.
 
2) 日本肥満症治療学会編. "治療困難例への対処の仕方". 肥満症の総合的治療ガイド. 2013, 98-9.
 

書評

最近チェックした商品履歴

Loading...